Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives

被引：3
|
作者：
Haddad, Fady G. [1 ]
Kourie, Hampig R. [1 ,2 ]
Kattan, Joseph [1 ]
机构：
[1] St Joseph Univ, Fac Med, Dept Oncol, Beirut, Lebanon
[2] Bordet Inst, Fac Med, Brussels, Belgium
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 03期
关键词：
EGFR; non-small-cell lung cancer; T790M; CISPLATIN PLUS GEMCITABINE; 1ST-LINE TREATMENT; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; GEFITINIB; AFATINIB; ERLOTINIB;
D O I：
10.2217/fon-2016-0325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：201 / 204
页数：4
相关论文
共 50 条
  • [21] Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives
    Madhurima R. Chetan
    Fergus V. Gleeson
    [J]. European Radiology, 2021, 31 : 1049 - 1058
  • [22] CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectives
    Berger, Lars Arne
    Riesenberg, Hendrik
    Bokemeyer, Carsten
    Atanackovic, Djordje
    [J]. LUNG CANCER, 2013, 80 (03) : 242 - 248
  • [23] Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives
    Chetan, Madhurima R.
    Gleeson, Fergus V.
    [J]. EUROPEAN RADIOLOGY, 2021, 31 (02) : 1049 - 1058
  • [24] Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non-Small-Cell Lung Cancer
    Yu, Jian
    Kane, Susan
    Wu, Jiong
    Benedettini, Elisa
    Li, Daiqiang
    Reeves, Cynthia
    Innocenti, Gregory
    Wetzel, Randy
    Crosby, Katherine
    Becker, Alison
    Ferrante, Michelle
    Cheung, Wan Cheung
    Hong, Xiqiang
    Chirieac, Lucian R.
    Sholl, Lynette M.
    Haack, Herbert
    Smith, Bradley L.
    Polakiewicz, Roberto D.
    Tan, Yi
    Gu, Ting-Lei
    Loda, Massimo
    Zhou, Xinmin
    Comb, Michael J.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (09) : 3023 - 3028
  • [25] EGFR mutation and response to chemotherapy in non-small-cell lung cancer (NSCLC) patients.
    Lee, KH
    Han, SW
    Jeong, S
    Kim, DW
    Chung, DH
    Im, SA
    Kim, TY
    Heo, DS
    Bang, YJ
    Kim, NK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [26] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer
    Giuseppe Giaccone
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 296 - 297
  • [27] Targeted Therapies for EGFR Exon 20 Insertion Mutation in Non-Small-Cell Lung Cancer
    Seo, Donghyun
    Lim, Jun Hyeok
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [28] Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancer
    Carlisle, Jennifer W.
    Ramalingam, Suresh S.
    [J]. FUTURE ONCOLOGY, 2019, 15 (08) : 805 - 816
  • [29] EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer
    Giaccone, G
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 296 - 297
  • [30] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
12345